Genomic medicine is transforming care for people with inherited and complex conditions,- including rare neurological and metabolic disorders, inherited cancers such as breast, ovarian and colorectal cancer, and conditions where early molecular diagnosis enables more personalised and effective treatment. Molecular diagnosis identifies diseases by analysing molecules – such as DNA, RNA, or proteins – in a laboratory.
Genomic testing can guide targeted cancer treatment, clarify uncertain diagnoses, inform proactive family screening for certain diseases and conditions, and support reproductive choices for conditions such as mitochondrial disease.
By integrating genomics into how we assess and diagnose conditions, and then plan and provide treatment, we can advance care, reduce variation, support prevention and deliver more personalised, effective and sustainable healthcare.
Newcastle hospitals have long‑standing strengths in clinical genetics, laboratory genomics and research, with particular expertise in rare disease, cancer genomics and advanced diagnostics.
Through our role in the North East and Yorkshire Genomic Laboratory Hub and the NHS Genomic Medicine Service, we support genomic testing at scale, ensuring patients across the region benefit from timely and fair access to high‑quality genomic diagnosis and care.
